Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Biliary Tract Diseases

Free Subscription Articles published in J Gastroenterol Retrieve available abstracts of 28 articles: HTML format Text format

Single Articles

May 2018
1. ORIMO T, Kamiyama T, Mitsuhashi T, Kamachi H, et al
   Impact of tumor localization on the outcomes of surgery for an intrahepatic cholangiocarcinoma.
   J Gastroenterol. 2018 May 2. pii: 10.1007/s00535-018-1469.
   PubMed     Text format     Abstract available
   
   
   April 2018
2. YAGI M, Tanaka A, Namisaki T, Takahashi A, et al
   Is patient-reported outcome improved by nalfurafine hydrochloride in patients with primary biliary cholangitis and refractory pruritus? A post-marketing, single-arm, prospective study.
   J Gastroenterol. 2018 Apr 16. pii: 10.1007/s00535-018-1465.
   PubMed     Text format     Abstract available
   
   
   December 2017
3. VITALE G, Gitto S, Raimondi F, Mattiaccio A, et al
   Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing.
   J Gastroenterol. 2017 Dec 13. pii: 10.1007/s00535-017-1423.
   PubMed     Text format     Abstract available
   
   
   
4. AOKI Y, Aida J, Kawano Y, Nakamura KI, et al
   Correction to: Telomere length of gallbladder epithelium is shortened in patients with congenital biliary dilatation: measurement by quantitative fluorescence in situ hybridization.
   J Gastroenterol. 2017 Dec 5. pii: 10.1007/s00535-017-1418.
   PubMed     Text format     Abstract available
   
   
   November 2017
5. PARK BK, Seo JH, Jeon HH, Choi JW, et al
   A nationwide population-based study of common bile duct stone recurrence after endoscopic stone removal in Korea.
   J Gastroenterol. 2017 Nov 30. pii: 10.1007/s00535-017-1419.
   PubMed     Text format     Abstract available
   
   
   
6. AOKI Y, Aida J, Kawano Y, Nakamura KI, et al
   Telomere length of gallbladder epithelium is shortened in patients with congenital biliary dilatation: measurement by quantitative fluorescence in situ hybridization.
   J Gastroenterol. 2017 Nov 15. doi: 10.1007/s00535-017-1411.
   PubMed     Text format     Abstract available
   
   
   August 2017
7. NAKAJIMA A, Seki M, Taniguchi S
   Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial.
   J Gastroenterol. 2017 Aug 24. doi: 10.1007/s00535-017-1383.
   PubMed     Text format     Abstract available
   
   
   April 2017
8. FLOREANI A, Tanaka A, Bowlus C, Gershwin ME, et al
   Geoepidemiology and changing mortality in primary biliary cholangitis.
   J Gastroenterol. 2017 Apr 1. doi: 10.1007/s00535-017-1333.
   PubMed     Text format     Abstract available
   
   
   December 2016
9. TAZUMA S, Unno M, Igarashi Y, Inui K, et al
   Evidence-based clinical practice guidelines for cholelithiasis 2016.
   J Gastroenterol. 2016.
   PubMed     Text format     Abstract available
   
   
   
10. NAKAZAWA T, Notohara K, Tazuma S, Tanaka A, et al
    The 2016 diagnostic criteria for primary sclerosing cholangitis.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available
    
    
    October 2016
11. UMEFUNE G, Kogure H, Hamada T, Isayama H, et al
    Procalcitonin is a useful biomarker to predict severe acute cholangitis: a single-center prospective study.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available
    
    
    
12. KAMISAWA T, Kuruma S, Chiba K, Tabata T, et al
    Biliary carcinogenesis in pancreaticobiliary maljunction.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available
    
    
    September 2016
13. OZAWA N, Yasuda I, Doi S, Iwashita T, et al
    Prospective randomized study of endoscopic biliary stone extraction using either a basket or a balloon catheter: the BasketBall study.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available
    
    
    July 2016
14. MOON SH, Kim MH, Lee JK, Baek S, et al
    Development of a scoring system for differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available
    
    
    June 2016
15. SHODA J, Matsuda A, Shida T, Yamamoto M, et al
    Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available
    
    
    
16. YAMADA N, Sanada Y, Tashiro M, Hirata Y, et al
    Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available
    
    
    May 2016
17. TANAKA A, Takikawa H, Mochida S, Koike K, et al
    Changing Nomenclature for PBC from "Primary Biliary Cirrhosis" to "Primary Biliary Cholangitis".
    J Gastroenterol. 2016.
    PubMed     Text format    
    
    
    April 2016
18. SUGIYAMA A, Kanno K, Nishimichi N, Ohta S, et al
    Periostin promotes hepatic fibrosis in mice by modulating hepatic stellate cell activation via alpha integrin interaction.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available
    
    
    March 2016
19. SOROIDA Y, Sato M, Hikita H, Hagiwara S, et al
    Pancreatic cysts in general population on ultrasonography: Prevalence and development of risk score.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available
    
    
    January 2016
20. ZEN Y, Kawakami H, Kim JH
    IgG4-related sclerosing cholangitis: all we need to know.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available
    
    
    November 2015
21. MOHRI D, Ijichi H, Miyabayashi K, Takahashi R, et al
    A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available
    
    
    
22. OKUSHIN K, Tsutsumi T, Enooku K, Fujinaga H, et al
    The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available
    
    
    
23. KOMAYA K, Ebata T, Fukami Y, Sakamoto E, et al
    Percutaneous biliary drainage is oncologically inferior to endoscopic drainage: a propensity score matching analysis in resectable distal cholangiocarcinoma.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available
    
    
    September 2015
24. DEGIORGIO D, Crosignani A, Colombo C, Bordo D, et al
    ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available
    
    
    July 2015
25. OKUNO M, Ebata T, Yokoyama Y, Igami T, et al
    Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available
    
    
    
26. UMEDA J, Itoi T
    Current status of preoperative biliary drainage.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available
    
    
    May 2015
27. ITATSU K, Yokoyama Y, Ebata T, Igami T, et al
    The value of preoperative screening colonoscopies in patients with biliary tract cancer.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available
    
    
    June 2014
28. TATEISHI R, Okanoue T, Fujiwara N, Okita K, et al
    Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study.
    J Gastroenterol. 2014.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: